The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells

Journal of Clinical Pharmacy and Therapeutics

Volumn 32, Issue 1, 2007, Pages 41-47

  Jin, C ^a   Wu, H ^a   Liu, J ^a   Bai, L ^b   Guo, G ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Xi'an Gaoxin Hospital   (China)

Author keywords

Drug delivery; Human breast carcinoma; Nanoparticle; Paclitaxel; Radiation

Indexed keywords

NANOPARTICLE; PACLITAXEL; POLYGLACTIN;

ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRAIN MCF 7; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DRUG RELEASE; EMULSION; EVAPORATION; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPOXIA; PHYSICAL CHEMISTRY; RADIATION DOSE; RADIOSENSITIVITY; SCANNING ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HUMANS; LACTIC ACID; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS;

EID: 33846849555     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2007.00796.x     Document Type: Article

References (25)

1. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in ridaotherapy. British Journal of Radiology, 26, 638-648.
2. Howes AE (1969) An estimation of changes in the proportion and absolute numbers of hypoxic cell after irradiation of transplanted C3H mouse mammary tumors. British Journal of Radiology, 42, 441-447.
3. Bush RS, Jenkin RDT, Allt WEC, Beale FA, Bean H, Dembo AJ, Pringle JG (1978) Definitive evidence for hypoxic cells influence in the cure in cancer therapy. British Journal of Cancer, 37 (Suppl. III), 302-306.
4. Brown JM (1979) Evidence for acutely hypoxic cells in mouse tumour and a possible mechanism of reoxygenation. British Journal of Radiology, 52, 650-656.
5. Horsman MR (1995) Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumors. Acta Oncologica, 34, 571-587.
6. Fiuorillo A, Tranfa F, Canale F et al. (1996) Primary Ewing's sarcoma of the maxilla, a rare and curable localization. Report of two cases, successfully treated by radiotherapy and systemic chemotherapy. Cancer Letters, 103, 177-182.
7. Shenoy MA, Singh BB (1992) Chemical radiosensitizers in cancer therapy. Cancer Investigation, 10, 533-551.
8. Yang RS, Eckardt JJ, Eilber FR et al. (1995) Surgical indications for Ewing's sarcoma of the pelvis. Cancer, 76, 1388-1397.
9. Mason KA, Milas L, Peters U (1995) Effect of taxol (Paclitaxel) alone and in combination with radiation on the gastrointestinal mucosa. International Journal of Radiation Oncology, Biology, Physics, 32, 1381-1389.
10. Bissett D, Kaye SB (1993) Taxol and taxotere - current status and future prospects. European Journal of Cancer, 29, 1228-1231.
11. Foa R, Norton L, Seidman AD (1994) Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. International Journal of Clinical and Laboratory Research, 24, 6-14.
12. McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC (1989) Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Annals of Internal Medicine, 111, 273-279.
13. Rowinsky EK, Eisenhower EA, Chaudry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered with paclitaxel (Taxol). Seminars in Oncology, 20, 1-15.
14. Tishler RB, Schiff PB, Geard CR, Hall EJ (1992) Taxol: a novel radiation sensitizer. International Journal of Radiation Oncology, Biology, Physics, 22, 613-617.
15. Tishler RB, Geard CR, Hall EJ, Schiff PB (1992) Taxol sensitizes human astrocytoma cells to radiation. Cancer Research, 52, 3495-3497.
16. Sinclair WK, Morton RA (1966) X-ray sensitization during the cell generation cycle of cultured Chinese hamster cells. Radiation Research, 29, 450-475.
17. Terasima R, Tolrnach LJ (1963) X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells. Science, 140, 490-492.
18. Withers HR, Mason K, Reid BO, Dubravsky N, Barkely HT, Brown BM, Smathers JB (1974) Response of mouse intestine to neurons and gamma rays in relation to dose and division cycle. Cancer, 34, 39-47.
19. Arbuck SG (1994) Taxol (paclitaxel): future directions. Annals of Oncology, 6, S59-S62.
20. Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews, 54, 631-651.
21. Yuan F, Leuning M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK (1994) Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in human tumor xenograft. Cancer Research, 54, 3352-3356.
22. Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL (1997) The mechanism of uptake of biodegradable microparticles in CaCO-2 cells is size dependant. Pharmaceutical Research, 14, 1568-1573.
23. Attawia MA, Borden MD, Herbert KM, Katti DS, Asrari F, Uhrich KE, Laurencin CT (2001) Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system. Journal of Controlled Release, 71, 193-202.
24. Kwon GS, Kataoka K (1995) Block copolymer micelles as longcirculating drug vehicles. Advanced Drug Delivery Reviews, 16, 295-309.
25. Konan YN, Gurney R, Allemann E (2002) Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. International Journal of Pharmaceutics, 233, 239-252.